The Repurposing of FDA-Approved Drugs as FtsZ Inhibitors against Mycobacterium tuberculosis : An In Silico and In Vitro Study.
Andrea Michel Tovar-NietoLuis Enrique Flores-PadillaBruno Rivas-SantiagoJuan Valentin Trujillo-PaezEdgar Eduardo Lara-RamirezYolanda Monserrath Jacobo-DelgadoJuan Ernesto López-RamosAdrián Rodríguez-CarlosPublished in: Microorganisms (2024)
Collectively, our findings demonstrate that the use of paroxetine and nebivolol is a promising strategy to help in the control of tuberculosis infection.